Pfizer and National Newspaper Publishers to Raise Awareness About Sickle Cell Disease | oneSCDvoice
  • Join Today!

Become a member and connect with:

  • An Active Online Community
  • Articles and Advice on SCD
  • Help Understanding Clinical Trials

Pfizer and National Newspaper Publishers to Raise Awareness About Sickle Cell Disease


Pfizer and the National Newspaper Publishers Association (NNPA) are collaborating to increase awareness about sickle cell disease and to discuss the need for improved patient care, as well as the importance of clinical trials.

The National Heart, Lung and Blood Institute (NHLBI) of the National Institutes of Health (NIH) estimates that sickle cell disease currently affects up to 100,000 Americans, making it the most common inherited blood disorder in the U.S.

The disease affects many ethnic groups, but people of African descent seem to be hit the hardest by the blood disorder, say researchers at the American Society of Hematology. The Centers for Disease Control and Prevention (CDC) statistics show that sickle cell disease occurs in approximately one out of every 365 African-American births.

https://www.onescdvoice.com/wp-content/uploads/2017/08/shutterstock_370657409-1000x480.jpg